INS and polycystic ovary syndrome: Insulin levels and HOMA-IR were markedly higher in the PCOS group (p < 0.001), confirming insulin resistance, whereas metformin and thymoquinone significantly lowered these values (p < 0.01), with metformin showing a slightly stronger effect.